Protara Therapeutics, Inc.TARANASDAQ
Loading
Debt to Equity Over TimeFair Value
Percentile Rank69
3Y CAGR-35.1%
5Y CAGR+25.7%
Year-over-Year Change
Debt-to-equity ratio
3Y CAGR
-35.1%/yr
Annual compound
5Y CAGR
+25.7%/yr
Recent deceleration
Percentile
P69
Within normal range
vs 5Y Ago
3.1x
Strong expansion
Streak
2 yr
Consecutive declineFair Value
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.02 | -36.2% |
| 2024 | 0.03 | -66.5% |
| 2023 | 0.08 | +28.0% |
| 2022 | 0.06 | +39.9% |
| 2021 | 0.04 | +719.5% |
| 2020 | 0.01 | - |
| 2019 | 0.00 | - |
| 2018 | 0.00 | -100.0% |
| 2017 | 0.00 | - |
| 2016 | 0.00 | - |